Patents by Inventor Krikor Bijian

Krikor Bijian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PURINE COMPOUNDS AND METHOD FOR THE TREATMENT OF CANCER
    Publication number: 20210171524
    Abstract: The present disclosure relates to novel compound of Formula I, (I) or a pharmaceutically acceptable salt or solvate thereof; wherein Ra, Rb, Rc, Rd, ring A and ring B are as defined herein, pharmaceutical compositions containing same and methods for the treatment of cancer using same.
    Type: Application
    Filed: June 21, 2019
    Publication date: June 10, 2021
    Inventors: Moulay A ALAOUI-JAMALI, Krikor BIJIAN, Dominik WERNIC
  • Purine compounds and method for the treatment of cancer
    Patent number: 10711002
    Abstract: The present disclosure relates to novel compound of Formula I, or a pharmaceutically acceptable salt or solvate thereof; wherein R1, R2, Ra, Rb and Rc are as defined herein, pharmaceutical compositions containing same and methods for the treatment of cancer using same.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: July 14, 2020
    Assignee: THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY
    Inventors: Moulay A. Alaoui-Jamali, Krikor Bijian, Dominik Wernic
  • PURINE COMPOUNDS AND METHOD FOR THE TREATMENT OF CANCER
    Publication number: 20190119279
    Abstract: The present disclosure relates to novel compound of Formula I, or a pharmaceutically acceptable salt or solvate thereof; wherein R1, R2, Ra, Rb and Rc are as defined herein, pharmaceutical compositions containing same and methods for the treatment of cancer using same.
    Type: Application
    Filed: April 21, 2017
    Publication date: April 25, 2019
    Inventors: Moulay A. ALAOUI-JAMALI, Krikor BIJIAN, Dominik WERNIC
  • Compounds targeting the cell invasion protein complex, their pharmaceutical compositions and methods of use thereof
    Patent number: 9085598
    Abstract: The present application relates to the compounds of formula I (I) as well as their use for inhibiting at least one of AKT-1, FAK and PKC? and in the treatment and/or prevention of metastatic diseases.
    Type: Grant
    Filed: October 26, 2012
    Date of Patent: July 21, 2015
    Assignees: The Royal Institution for the Advancement of Learning/McGill University, Ocean University of China
    Inventors: Moulay A. Alaoui-Jamali, Krikor Bijian, Jiang Tao
  • Compounds Targeting the Cell Invasion Protein Complex, Their Pharmaceutical Compositions and Methods of Use Thereof
    Publication number: 20140256659
    Abstract: The present application relates to the compounds of formula I (I) as well as their use for inhibiting at least one of AKT-1, FAK and PKC? and in the treatment and/or prevention of metastatic diseases.
    Type: Application
    Filed: October 26, 2012
    Publication date: September 11, 2014
    Inventors: Moulay A. Alaoui-Jamali, Krikor Bijian, Jiang Tao